Iziyobisi zokuxhatshazwa okuDityanisiweyo indebe(Umchamo)
Usetyenziso olucetywayo
Amachiza e-Abuse Integrated Integrated Cup(Umchamo) luvavanyo olukhawulezayo olubonwayo lomgangatho, ubhaqo olucingelwayo lwalo naliphi na indibaniselwano yamachiza kunye nokuGcuka kokuxhatshazwa kwisampulu zomchamo womntu kugxininiso olusikiweyo oludweliswe ngezantsi:
Uvavanyo | Isilinganisi | Ukunqunyulwa (ng/mL) |
I-AMP | IAmphetamine | 1,000 |
BZO | Oxazepam | 300 |
COC | Cocaine/Benzoylecgonine | 300 |
KWAMET | IMethamphetamine | 1,000 |
OPI | Morphine | 2,000 |
I-THC | I-11-nor- Δ9-THC-9-carboxylic acid | 50 |
Ukukrexeza | SG/PH/Oxidants/CRE/NIT/GLUT |
Umgaqo
The Drugs of Abuse Integrated Cup(Umchamo) luvavanyo logonyo olusekelwe kumgaqo wokuzibophelela okukhuphisanayo.Amachiza anokuthi abekhona kwisampulu yomchamo akhuphisana ngokuchasene ne-conjugate yawo yechiza ngokwahlukeneyo kwiziza ezibophelelayo kwi-antibody yazo ethile.
Ngexesha lokuvavanya, inxalenye yesampula yomchamo ihambela phezulu ngesenzo se-capillary.Ichiza, ukuba likhona kumzekelo womchamo ongaphantsi koxinaniso olusikiweyo, aliyi kuzalisa iisayithi ezibophelelayo ze-antibody ethile.I-antibody iya kuthi emva koko iphendule nge-conjugate ye-drug-protein kunye nomgca obonakalayo onemibala uya kubonakala kwindawo yovavanyo lomgca weyeza elihambelanayo.Ubukho bechiza ngaphezu koxinaniso olusikiweyo kumzekelo womchamo buya kuzalisa zonke iindawo ezibophelelayo ze-antibody.Ngoko ke, akukho mgca wemibala uya kwenza kwingingqi yovavanyo.
Umzekeliso womchamo oneziyobisi awusayi kuvelisa umgca onemibala kwindawo ethile yovavanyo lomtya ngenxa yokhuphiswano lwamachiza, ngelixa umboniso womchamo ongenalo ichiza uya kuvelisa umgca kwindawo yovavanyo ngenxa yokungabikho kokhuphiswano ngamachiza.Ukuze usebenze njengolawulo lwenkqubo, umgca onemibala uya kuhlala ubonakala kwingingqi yolawulo, ebonisa ukuba umthamo ofanelekileyo we-specimen wongeziwe kwaye i-membrane wicking yenzeke.
Ukukrexeza kukuphazamisana nomboniso womchamo ngenjongo yokuguqula iziphumo zovavanyo.Ukusetyenziswa kwabakrexezi kunokubangela iziphumo ezingezizo ezingalunganga kuvavanyo lweziyobisi ngokuphazamisana novavanyo lokuhlola kunye/okanye nokutshabalalisa amayeza akhoyo kumchamo.I-Dilution isenokuthi isetyenziswe kwiinzame zokuvelisa iziphumo zovavanyo olungalunganga lwechiza.
Izinto eziphathekayo
Izixhobo ezibonelelweyo
Iikomityi zovavanyo ezipakishwe umntu ngamnye ezineyeza ezidityanisiweyo zovavanyo lweephaneli zovavanyo | |
Iicaps | Izitshixo |
Faka iphakheji | UmbalaIkhadi |
Izinto Eziyimfuneko Kodwa Ezingabonelelwanga
Isibali-xesha | Centrifuge |
Ulawulo olulungileyo nolungalunganga |
Iireagents
Uvavanyo ngalunye lunemicu ye-reagent efakwe kwindlu yeplastiki.Ubungakanani be-antigen nganye kunye/okanye i-antibody eqatywe kumgca ingaphantsi kwe-0.001 mg ye-antigen conjugates kunye nebhokhwe ye-anti-Rabbit IgG antibodies, kwaye ingaphantsi kwe-0.0015 mg kumalungu e-antibody.
Indawo yolawulo yovavanyo ngalunye iqulethe i-anti-igG yebhokhwe echasene nemivundla.Indawo yovavanyo kunye nephedi ye-conjugate yovavanyo ngalunye iqulethe i-antigen elandelayo kunye ne-antibody components:
Uvavanyo | Indawo yoVavanyo | I-Conjugate Pad |
I-AMP | Amphetamine bovine protein antigen conjugate | I-Monoclonal anti-amphetamine kunye nomvundla we-antibody-colored particle complex |
BZO | Oxazepam bovine protein antigen conjugate | I-Monoclonal anti-oxazepam kunye nomvundla we-antibody-colored particle complex |
COC | Benzoylecgonine bovine protein antigen conjugate | I-Monoclonal anti-benzoylecgonine kunye nomvundla we-antibody-colored particle complex |
KWAMET | Methamphetamine bovine protein antigen conjugate | I-Monoclonal anti-methamphetamine kunye nomvundla we-antibody-colored particle complex |
OPI | I-Monoclonal anti-morphine antibody | I-Morphine bovine protein ye-antigen conjugate kunye nomvundla we-antibody-colored particle complex |
I-THC | THC bovine protein antigen conjugate | I-Monoclonal anti-THC kunye nomvundla we-antibody-colored particle complex |
Ngenxa yokukrexeza
IPadi yoKukrexeza | Isalathisi esisebenzayo | I-Buffer kunye ne-Non-reactive Ingredient |
pH | 0.06% | 99.94% |
Ubunzima obuthile (SG) | 0.25% | 99.75% |
Ii-Oxidants/PCC OXI/PCC) | 0.36% | 99.64% |
ICreatinine (CRE) | 0.04% | 99.96% |
I-Nitrite (NIT) | 0.07% | 99.93% |
IGlutaraldehyde (GLUT) | 0.02% | 99.98% |
Ukulumkela
★ Ukusetyenziswa koxilongo lwe-in vitro kuphela.
★ Musa ukusebenzisa emva komhla wokuphelelwa oboniswe kwiphakheji.Musa ukusebenzisa uvavanyo ukuba isikhwama se-foil sonakalisiwe.Musa ukuphinda usebenzise iimvavanyo.
★ Le khithi iqulethe iimveliso zemvelaphi yezilwanyana.Ulwazi oluqinisekisiweyo lwemvelaphi kunye / okanye ubume bococeko bezilwanyana aluqinisekisi ngokupheleleyo ukungabikho kwee-agent ze-pathogenic ezihambisayo.Kuyacetyiswa ke ngoko ukuba ezi mveliso ziphathwe njengezinosulelo, kwaye ziphathwe ngokuqwalasela imiqathango yokhuseleko eqhelekileyo (umz., ungatyi okanye ungaphefumli).
• Kuphephe ukungcoliseka ngokunqamlezayo kwesampulu ngokusebenzisa isikhongozeli esitsha sokuqokelelwa kwesampulu kumzekelo ngamnye ofunyenweyo.
★ Funda yonke inkqubo ngononophelo phambi kovavanyo.
★ Sukutya, usele okanye utshaye kwindawo apho imizekelo neekiti ziphathwa khona.Phatha yonke imizekelo ngokungathi inee-arhente ezosulelayo.Qwalasela izilumkiso ezimiselweyo ngokuchasene nobungozi bemicrobiological kuyo yonke inkqubo kwaye ulandele iinkqubo ezisemgangathweni zokulahlwa ngokufanelekileyo kwesampulu.Nxiba iimpahla ezikhuselayo ezifana needyasi zaselabhoratri, iiglavu ezilahlwayo kunye nokhuseleko lwamehlo xa imizekelo ivavanywa.
★ Ukufuma kunye nobushushu bunokuchaphazela kakubi iziphumo.
★ Izinto zokuvavanya ezisetyenzisiweyo kufuneka zilahlwe ngokuhambelana nemimiselo yendawo.
Ukugcinwa kunye nokuzinza
✽ Ikhithi kufuneka igcinwe kwi-2-30°C de kube ngumhla wokuphelelwa kwexesha uprintwe kwisingxobo esivaliweyo.
✽ Uvavanyo maluhlale kwisingxobo esitywiniweyo de lusetyenziswe.
✽ Musa ukuba ngumkhenkce.
✽ Iikiti kufuneka zigcinwe zingangeni ngqo elangeni.
✽ Kufuneka kuthathwe unonophelo ukukhusela amalungu ekhithi ekosulelweni.Musa ukusebenzisa ukuba kukho ubungqina bokungcoliseka kwe-microbial okanye imvula.Ungcoliseko lwebhayoloji lwezixhobo zokukhupha, izikhongozeli okanye iirejenti kunokukhokelela kwiziphumo ezingezizo.
Ukuqokelelwa komfanekiso kunye noGcino
✔ The Drugs of Abuse Integrated Cup(Umchamo) enzelwe ukusetyenziswa nomchamo womntu kuphela.
✔ Umchamo oqokelelwe nangaliphi na ixesha losuku usenokusetyenziswa.
✔ Imizekelo yomchamo kufuneka iqokelelwe kwizikhongozeli ezicocekileyo, ezomileyo.
✔ Imizekelo ye-turbid kufuneka ifakwe kwi-centrifuged, ihluzwe, okanye ivunyelwe ukuba ihlale kwaye kuphela i-supernatant ecacileyo kufuneka isetyenziswe kuvavanyo.
✔ Yenza uvavanyo ngoko nangoko emva kokuqokelela isampuli.Musa ukushiya iisampulu kwindawo yobushushu begumbi ixesha elide.Iisampuli zomchamo zingagcinwa kwi-2-8 ° C ukuya kwii-2 iintsuku.Ukugcina ixesha elide, imizekelo kufuneka igcinwe ngaphantsi kwe-20°C.
✔ Zisa iisampulu kwiqondo lobushushu legumbi ngaphambi kovavanyo.Iisampulu ezikhenkcezisiweyo kufuneka zinyibilike ngokupheleleyo kwaye zixutywe kakuhle phambi kovavanyo.Kuphephe ukukhenkceza okuphindaphindiweyo kunye nokunyibilika kwemizekelo.
✔ Ukuba iisampuli ziza kuthunyelwa, zipakishe ngokuhambelana nayo yonke imimiselo esebenzayo yokuthutha i-etiological agents.
Inkqubo
Zisa iimvavanyo, imizekelo, kunye/okanye nolawulo kwiqondo lobushushu legumbi (15-30°C) phambi kokusetyenziswa.
1.Susa ikomityi ngesitshixo sayo kwisingxobo esitywiniweyo kwaye uyisebenzise ngokukhawuleza.
2.Umnikeli ubonelela ngesampulu yomchamo ekomityini kunye nesikrufu sekepusi kuyo.
3.Imihla yomnikeli kunye neleyibhile yomzimba.
4.Donor screws key deasil for 180 °, kwaye uqale isibali-xesha ngokukhawuleza.
5.I-Operator ijonga i-cap ukuba iqinile.
6.Susa ileyibhile ye-peel-off.
7.Hlola ileyibhile yeqondo lokushisa kwi-2-4 imizuzu emva kokuqokelela i-specimen.Umbala oluhlaza uya kubonakala ubonisa ubushushu bomzekelo womchamo.Uluhlu olufanelekileyo lwe-specimen engaxutywanga yi-90-100 ° F (32-38 ° C).
8.Iziphumo zovavanyo lweziyobisi ziboniswa bubukho okanye ukungabikho kwebhanti enemibala kwindawo yesiphumo.Isiphumo kufuneka sifundwe ngemizuzu emi-5.Musa ukutolika umphumo emva kwemizuzu esi-8.
9. Ukukrexeza, xa kuthelekiswa nekhadi lombala, kwaye iziphumo kufuneka zifundwe ngemizuzu emi-2.
10. Iziphumo zovavanyo oluqinisekileyo kufuneka zingqinwe yenye indlela yovavanyo.Thumela ikomityi kunye nesampulu yomchamo ingaguquki kwilebhu ye-toxicology ukuze ingqinwe.

Ukutolikwa kweziPhumo
(Jonga umfanekiso ongaphambili)
OKUHLE: Linye kuphela iqela elinemibala elivelayo,kummandla wolawulo (C).Akukho bhanti yemibala ibonakala kwindawo yovavanyo (T) yechiza ekuthethwa ngalo.Isiphumo esihle sibonisa ukuba ukugxilwa kweziyobisi kudlula inqanaba elibonakalayo.
I-NEGATIVE: Iibhanti ezimbini ezinemibala ziyavelakwi-membrane.Elinye ibhendi livela kummandla wolawulo (C) kwaye elinye ibhendi livela kwindawo yovavanyo (T) yechiza ekuthethwa ngalo.Isiphumo esibi sibonisa ukuba
Uxinzelelo lweziyobisi lungaphantsi kwinqanaba elibonakalayo.
AYILUNGILEYO: Ibhendi yolawulo ayibonakali.Iziphumo zalo naluphi na uvavanyo olungakhange luvelise ibhendi yolawulo ngexesha elichaziweyo kufuneka zilahlwe.Nceda ujonge inkqubo kwaye uphinde ngovavanyo olutsha.Ukuba ingxaki iyaqhubeka, yeka ukusebenzisa ikhithi ngoko nangoko kwaye uqhagamshelane nomsasazi wakho wendawo.
Ngenxa yokukrexeza:
Iziphumo zifunyanwa ngokuthelekisa ngokubonakalayo iibhloko zombala ezisabelayo kuluhlu lovavanyo kwiibhloko zombala eziprintiweyo kwi-canister.
PHAWULA:
I-1.Ubunzima bombala kummandla wokuvavanya (T) bunokwahluka ngokuxhomekeke kugxininiso lwabahlalutyi abakhoyo kwi-specimen.Ngoko ke, nawuphi na umthunzi wombala kummandla wokuvavanya (T) kufuneka uthathwe njengento engalunganga.Nceda uqaphele ukuba olu luvavanyo lomgangatho kuphela, kwaye alukwazi ukumisela ugxininiso lwabahlalutyi kumzekelo.
I-2.I-specimen enganelanga umthamo, inkqubo yokusebenza engalunganga okanye iimvavanyo eziphelelwe lixesha zizona zizathu ezinokuthi zenzeke zokungaphumeleli kwebhendi yolawulo.
Ulawulo lwemeko
★ Ulawulo lwenkqubo lwangaphakathi lubandakanyiwe kuvavanyo.Ibhendi enemibala evela kummandla wolawulo (C) ithathwa njengolawulo lwangaphakathi olulungileyo lwenkqubo, eqinisekisa umthamo owaneleyo wesampuli kunye nobuchule benkqubo obuchanekileyo.
★ Ulawulo lwangaphandle alubonelelwanga nale khithi.Kucetyiswa ukuba ulawulo oluqinisekileyo nolungalunganga luvavanywe njengenkqubo efanelekileyo yaselabhoratri yokuqinisekisa inkqubo yovavanyo kunye nokuqinisekisa ukusebenza kakuhle kovavanyo.
Imida yoVavanyo
A. Ukuchaneka
Ukuchaneka kwe-Drugs of Abuse Integrated Cup(Urine) yasekwa ngokuqhuba iisampuli zomchamo ngokuchasene ne-GC/MS.
IAmphetamine(Ixabiso le-GC / MS lilinganiswe kwi-amphetamine): Kulo cwaningo, ikhulu lesithathu (103) iisampulu zomchamo ezimbi kunye ne-positive (0 ukuya kwi-46,922 ng / mL) zavavanywa kwaye zithelekiswa ne-GC / MS.Ugxininiso lweempawu ezimbini ezingafaniyo zaqinisekiswa nge-GC / MS ukuba zisondele kwixabiso lokunqunyulwa (1,064 kunye ne-1,117 ng / mL).Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | |||
Iindebe zoVavanyo lweZiyobisi ezininzi | GC/MS negative | Kufuphi ukunqunyulwa okungalunganga (75% ukunqunyulwa) | Kufuphi ukunqunyulwa okulungileyo (ukunqunyulwa ukuya kwi-125%) | GC/MS positive (>125%) |
(+) | 0 | 0 | 5 | 41 |
(-) | 48 | 7 | 2 | 0 |
Iyonke | 48 | 7 | 7 | 41 |
IsiVumelwano esiNgcono: 95.8% isiVumelwano esiNegative: 100% IsiVumelwano sisonke: 98.1%
Benzodiazepines(Imilinganiselo ye-GC / MS ilinganiswe kwi-oxazepam, i-nordiazepam, okanye i-alprazolam): Kulo cwaningo, iisampuli ezingamashumi alithoba anesithoba (99) ezingalunganga kunye nezilungileyo zomchamo (0 ukuya>> 10,000 ng / mL) zavavanywa kwaye zithelekiswa neGC / MS.Imizekelo emithandathu engahambelaniyo yaqinisekiswa nge-GC / MS ukuba ibe noxinzelelo lwe-oxazepam - 292 kunye ne-319 ng / mL, kunye ne-alprazolam - 315, 317, 367 kunye ne-488 ng / mL.Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | |||
Iindebe zoVavanyo lweZiyobisi ezininzi | GC/MS negative | Kufuphi ukunqunyulwa okungalunganga (75% ukunqunyulwa) | Kufuphi ukunqunyulwa okulungileyo (ukunqunyulwa ukuya kwi-125%) | GC/MS positive (>125%) |
(+) | 3 | 1 | 5 | 36 |
(-) | 47 | 5 | 2 | 0 |
Iyonke | 50 | 6 | 7 | 36 |
IsiVumelwano esiNgcono: 95.3% isiVumelwano esiNegetive: 92.9% IsiVumelwano sisonke: 93.9%
Cocaine(Ixabiso le-GC / MS lilinganiswe kwi-benzoylecgonine): Kolu phononongo, ikhulu elineshumi (110) iisampulu zomchamo ezingalunganga kunye ne-positive (0 ukuya kwi-245,682 ng / mL) zavavanywa kwaye zithelekiswa neGC / MS.Ukugxininiswa kweempawu ezimbini ezingafaniyo zaqinisekiswa nge-GC / MS ukuba zisondele kwixabiso lokunqunyulwa (284 kunye ne-328 ng / mL).Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | |||
Iindebe zoVavanyo lweZiyobisi ezininzi | GC/MS negative | Kufuphi ukunqunyulwa okungalunganga (75% ukunqunyulwa) | Kufuphi ukunqunyulwa okulungileyo (ukunqunyulwa ukuya kwi-125%) | GC/MS positive (>125%) |
(+) | 0 | 1 | 4 | 51 |
(-) | 47 | 6 | 1 | 0 |
Iyonke | 47 | 7 | 5 | 51 |
IsiVumelwano esiNgcono: 98.2% isiVumelwano esiNegative: 98.1% IsiVumelwano sisonke: 98.2%
IMethamphetamine(Imilinganiselo ye-GC / MS ilinganiswe kwi-methamphetamine): Kolu cwaningo, ikhulu elinesihlanu (115) iisampulu zomchamo ezingalunganga kunye ne-positive (0 ukuya kwi-82,106 ng / mL), zavavanywa kwaye zithelekiswa ne-GC / MS.Ugxininiso lweempawu ezimbini ezingafaniyo zaqinisekiswa nge-GC / MS ukuba zisondele kwixabiso lokunqunyulwa (1,007 kunye ne-1,040 ng / mL).Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | |||
Iindebe zoVavanyo lweZiyobisi ezininzi | GC/MS negative | Kufuphi ukunqunyulwa okungalunganga (75% ukunqunyulwa) | Kufuphi ukunqunyulwa okulungileyo (ukunqunyulwa ukuya kwi-125%) | GC/MS positive (>125%) |
(+) | 0 | 0 | 4 | 57 |
(-) | 44 | 8 | 2 | 0 |
Iyonke | 44 | 8 | 6 | 57 |
IsiVumelwano esiNgcono: 96.8% isiVumelwano esiNegative: 100% IsiVumelwano sisonke: 98.3%
I-OPI (inkcazo ye-GC / MS yixabiso le-morphine okanye i-codeine): Kulo cwaningo, ikhulu elinesihlanu (105) iisampulu zomchamo ezimbi kunye ne-positive (0 ukuya kwi-50236 ng / ml) zavavanywa kwaye zithelekiswa ne-GC / MS.Ukugxininiswa kweempawu ezimbini ezingafaniyo zaqinisekiswa nge-GC / MS ukuba zisondele kwixabiso le-cutoff (1836 kunye ne-2041.5 ng / ml).Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | ||||
Drug Screen | GC/MS Engalunganga (0 ng/ml ukuya ku-75%) | Kufutshane ukusika okungalunganga (75%- Yisuse ecaleni) | Kufutshane ukusika kulungileyo (ukunqunyulwa ukuya125%) | GC/MS Positive (>125%) | % Isivumelwano neGC/MS |
(+) | 0 | 1 | 7 | 33 | 97.6 % |
(-) | 56 | 7 | 1 | 0 | 98.4 % |
Iyonke | 56 | 8 | 8 | 33 | 98.1 % |
IsiVumelwano esiSihle: 97.6% kunye nesiVumelwano esiNegative: 98.4%
I-THC(amaxabiso e-GC/MS alinganiswe kwi-11-nor-9-THC-9-COOH): Kolu phononongo, ikhulu elinamashumi amabini anesibini (122) iisampulu ezingalunganga zomchamo (0 ukuya> 2,000 ng/mL) zavavanywa kwaye zathelekiswa. kunye neGC/MS.Ukugxininiswa kweempawu ezintathu ezingafaniyo zaqinisekiswa nge-GC / MS ukuba zisondele kwixabiso lokunqunyulwa (48, 50 kunye ne-54 ng / mL).Iziphumo zishwankathelwa ngezantsi:
(-) | (+) | |||
Iindebe zoVavanyo lweZiyobisi ezininzi | GC/MS negative | Kufuphi ukunqunyulwa okungalunganga (75% ukunqunyulwa) | Kufuphi ukunqunyulwa okulungileyo (ukunqunyulwa ukuya kwi-125%) | GC/MS positive (>125%) |
(+) | 0 | 1 | 7 | 53 |
(-) | 45 | 14 | 2 | 0 |
Iyonke | 45 | 15 | 9 | 53 |
IsiVumelwano esiNgcono: 96.8% isiVumelwano esiNegative: 98.3% IsiVumelwano sisonke: 97.5%
B. Uvakalelo
Uvakalelo lwe-QuikCup Drugs of Abuse Integrated Cup (Urine) lugqitywe ngokuvavanya iGC/MS yolawulo oluqinisekisiweyo kwindawo engalunganga, -50% yokunqunyulwa, -25% yokunqunyulwa, ukunqunyulwa, +25% ukunqunyulwa, + 50% yokunqunyulwa kunye namaxesha ama-3 anqunyelwe ukunqunyulwa.Iziphumo zishwankathelwa ngezantsi:
Uluhlu lweziyobisi.(Uluhlu olusikiweyo) | n | I-AMP | BZO | COC | |||
- | + | - | + | - | + | ||
Ibi | 50 | 50 | 50 | 50 | |||
50% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
75% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
Yisuse ecaleni | 50 | 16 | 34 | 17 | 33 | 11 | 39 |
125% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
150% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
3X Ukunqunyulwa | 50 | 50 | 50 | 50 |
Uluhlu lweziyobisi.(Uluhlu olusikiweyo) | n | KWAMET | OPI | I-THC | |||
- | + | - | + | - | + | ||
Ibi | 50 | 50 | 50 | 50 | |||
50% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
75% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
Yisuse ecaleni | 50 | 23 | 27 | 13 | 37 | 17 | 33 |
125% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
150% Ukunqunyulwa | 50 | 50 | 50 | 50 | |||
3X Ukunqunyulwa | 50 | 50 | 50 | 50 |
B. Ukuchaza ngokuthe ngqo
Ezi theyibhile zilandelayo zidwelisa ugxininiso lweekhompawundi (ng/mL) ngasentla apho iQuikCup Drugs of Abuse Integrated Integrated Cup(Urine) ichonge iziphumo ezilungileyo ngemizuzu emi-5.
IiCompounds ezinxulumene neAmphetamine | Ugxininiso (ng/mL) |
d-Amphetamine | 1,000 |
I-l-Amphetamine | 100,000 |
3,4-Methylenedioxyamphetamine (MDA) | 1,250 |
IParamethoxyamphetamine (PMA) | 625 |
Phentermine | 1,250 |
Tyramine | 100,000 |
IiCompounds eziNxulumene neBenzodiazepine | Ugxininiso (ng/mL) |
Alprazolam | 125 |
Bromazepam | 625 |
I-Chlordiazepoxide | 2,500 |
Clobazam | 63 |
I-Clonazepam | 2,500 |
Clorazepate dipotassium | 3,330 |
Delorazepam | 2,500 |
Desalkylflurazepam | 250 |
Diazepam | 250 |
Estazolam | 5,000 |
I-Flunitrazepam | 375 |
(±) ILorazepam | 1,250 |
RS-Lorazepam glucuronide | 1,250 |
Midazolam | 100,000 |
Nitrazepam | 25,000 |
Norchlordiazepoxide | 250 |
Nordiazepam | 500 |
Oxazepam | 300 |
Sulindac | 100,000 |
Temazepam | 63 |
I-Triazolam | 5,000 |
IiCompounds ezinxulumene neCocaine | Ugxininiso (ng/mL) |
Ibenzoylecgonine | 300 |
Cocaine | 1,000 |
Ecgonine | 100,000 |
IiCompounds ezinxulumene nentsangu | Ugxininiso (ng/mL) |
11-okanye-∆9-THC-9-COOH | 50 |
11-okanye-∆8-THC-9-COOH | 50 |
∆9-tetrahydrocannabinol | 15,000 |
∆8-tetrahydrocannabinol | 15,000 |
I-Cannabinol | >20,000 |
IiCompounds ezinxulumene neMethamphetamine | Ugxininiso (ng/mL) |
I-Chloroquine | 25,000 |
I-Fenfluramine | 12,500 |
I-MDEA | 50,000 |
MDMA | 313 |
Mephentermine hemisulfate ityuwa | 31,250 |
I-l-Methamphetamine | 10,000 |
d-Methamphetamine | 1,000 |
PMMA | 625 |
OPI -Related Compounds | Ugxininiso (ng/mL) |
Morphine | 2,000 |
I-acetylcodeine | 1,563 |
Buprenorphine | 25,000 |
Codeine | 500 |
I-Diacetyl Morphin (iHeroin) | 1,250 |
Dihydrocodeine | 1,563 |
Ethylmorphine | 800 |
IHydrocodone | 50,000 |
I-Hydromorphone | 25,000 |
I-6-Monoacetylmorphine | 1,250 |
I-Morphine-3-β-d-glucuronid | 12,500 |
Nalorphine | 100,000 |
Thebaine | 50,000 |
Uphononongo lwenziwe ukumisela ukuphinda-phinda ukusebenza kwakhona kovavanyo kunye neekhompawundi ezifakwe kwisitokhwe se-PBS esingenaziyobisi.Ezi khompawundi zilandelayo zibonisa ukuba akukho ziziphumo zingezizo zobuxoki kwi-QuikCup Drugs of Abuse Integrated Cup(Umchamo) xa zivavanyiwe kuxinzelelo ukuya kwi-100 µg/mL.
I-acetaminophen | I-Ethanol |
I-acetone | Furosemide |
Albumin | IGuiacol glyceryl ether |
Ampicillin | IHemoglobin |
Aspartame | Ibuprofen |
I-Aspirin | (±)-Isoproterenol |
Atropine | Lidocaine |
Benzocaine | N-Methyl-ephedrine |
Bilirubin | (+)-Naproxen |
Icaffeine | Oxalic acid |
I-Chlorpheniramine | I-Penicillin-G |
I-Creatine | Pheniramine |
I-Dextrorphan tartrate | Phenothiazine |
I-4-Dimethylaminoantipyrine | L-Phenylephrine |
IDopamine | β-Phenylethylamine |
(±)-Ephedrine | I-Quinidine |
Erythromycin | I-Ranitidine |
Iimbekiselo zoncwadi
1.Baselt RC.Ukulahlwa kweziyobisi ezinetyhefu kunye neekhemikhali kuMntu.2nd ed.UDavis: Ushicilelo lweBiomedical;1982.
2.Hawks RL, Chiang CN, ed.Uvavanyo lomchamo lweziyobisi zokuSebenzisa kakubi.I-Rockville: iSebe lezeMpilo kunye neeNkonzo zoLuntu, iZiko leSizwe loSetyenziso lweZiyobisi;1986.
3.UkuSetyenziswa Gwenxa kweZiyobisi kunye noLawulo lweeNkonzo zeMpilo yeNgqondo.Izikhokelo eziSinyanzelo kwiiNkqubo zoVavanyo lweZiyobisi kwi-Federal Workplace.Irejista ye-53 Federal;1988.
4.McBay AJ.Itekhnoloji yohlalutyo lweziyobisi--imigibe kunye neengxaki zokuvavanywa kweziyobisi.UClin Chem.1987 Okt;33 (11 Suppl): 33B-40B.
5.Gilman AG, Goodman LS, Gilman A, ed.UGoodman kunye noGilman's The Pharmacological Basics of Therapeutics.6th ed.ENew York: eMacmillan;1980.